Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Medicine and Biotech News

Medicine and Biotech Sector Information

Sector Value: 26,567.25
Change:  308.91 (1.18%)
Open: 26,258.34
High: 26,607.14
Low: 25,934.10
Yest. Close: 26,258.33984
Medicine and Biotech Live PriceLast checked at -
Scancell confirms advanced talks on takeover of Neuphoria; eyes Nasdaq
1 hour ago

Scancell confirms advanced talks on takeover of Neuphoria; eyes Nasdaq

(Alliance News) - Scancell Holdings PLC on Friday confirmed it was in advanced talks to acquire Neuphoria Therapeutics Inc, which could facilitate a N...

Scancell confirms advanced talks on takeover of Neuphoria; eyes Nasdaq
1 hour ago

Scancell confirms advanced talks on takeover of Neuphoria; eyes Nasdaq

(Alliance News) - Scancell Holdings PLC on Friday confirmed it was in advanced talks to acquire Neuphoria Therapeutics Inc, which could facilitate a N...

TRADING UPDATES: Zephyr adds acreage; Hercules funding package
2 hours ago

TRADING UPDATES: Zephyr adds acreage; Hercules funding package

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Crism losses widen as it spends on clinical development
3 hours ago

Crism losses widen as it spends on clinical development

(Sharecast News) - Crism Therapeutics reported a wider full-year loss on Friday, reflecting increased investment in clinical and pre-clinical developm...

Crism losses widen as it spends on clinical development
3 hours ago

Crism losses widen as it spends on clinical development

(Sharecast News) - Crism Therapeutics reported a wider full-year loss on Friday, reflecting increased investment in clinical and pre-clinical developm...

AstraZeneca's, Daiichi's Datroway recommended for further EU approval
3 hours ago

AstraZeneca's, Daiichi's Datroway recommended for further EU approval

(Alliance News) - AstraZeneca PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended appr...

WINNERS & LOSERS: Distribution Finance optimistic for annual results
5 hours ago

WINNERS & LOSERS: Distribution Finance optimistic for annual results

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

EARNINGS: CRISM, Ampeak and Ethtry widen 2025 pretax loss
5 hours ago

EARNINGS: CRISM, Ampeak and Ethtry widen 2025 pretax loss

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:

WINNERS & LOSERS: British American Tobacco announces buyback
6 hours ago

WINNERS & LOSERS: British American Tobacco announces buyback

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

TRADING UPDATES: Caspian reports progress; Arkle nears Erongo drilling
22 hours ago

TRADING UPDATES: Caspian reports progress; Arkle nears Erongo drilling

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
1 day ago

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

IN BRIEF: Agronomics investee Tropic buys banana business Rahan
1 day ago

IN BRIEF: Agronomics investee Tropic buys banana business Rahan

Agronomics Ltd - Isle of Man-based investor in cellular agriculture - Portfolio company Tropic Biosciences UK Ltd acquires Rahan Meristem (1998) Ltd ...

TRADING UPDATES: Time Finance earnings up; Aptitude Software wins deal
1 day ago

TRADING UPDATES: Time Finance earnings up; Aptitude Software wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Hutchmed China reports positive phase two fanregratinib study data
1 day ago

Hutchmed China reports positive phase two fanregratinib study data

(Alliance News) - Hutchmed China Ltd on Thursday reported positive phase two data for fanregratinib in patients with intrahepatic cholangiocarcinoma, ...

WINNERS & LOSERS: Ingenta falls after future earnings warning
1 day ago

WINNERS & LOSERS: Ingenta falls after future earnings warning

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.